Agentix Corp logo

Agentix Corp

$ 0.10 0 (0%) 11:14 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 3.97M
Enterprise V:
$ 4.47M
Volume:
-
Avg Vol (2M):
1.50K
Volume:
-
Market Cap $:
3.97M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.50K
Enterprise Value $:
4.47M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Agentix Corp is a biotechnology company. It is engaged in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. Its principal business objective is to develop both science-driven synthetic and natural cannabinoid therapeutics that address unmet medical needs and continue to drive innovations in the endocannabinoid space.
Name Current Vs Industry Vs History
Cash-To-Debt N/A
N/A
N/A
Equity-to-Asset -112.91
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1440.31
Distress
Grey
Safe
Beneish M-Score -163.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.69
9-Day RSI 38.8
14-Day RSI 37.97
6-1 Month Momentum % -50.79
12-1 Month Momentum % -91.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -285.6
Name Current Vs Industry Vs History
Operating Margin % -259200
Net Margin % -259200
ROA % -5728.18

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.53
EV-to-EBITDA -1.53
EV-to-Revenue 3969
EV-to-FCF -45.2
Earnings Yield (Greenblatt) % -65.17

Financials

AGTX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:AGTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.001
EPS (TTM) ($) -0.069
Beta 0.8
Volatility % 112.07
14-Day RSI 37.97
14-Day ATR ($) 0.003941
20-Day SMA ($) 0.10377
12-1 Month Momentum % -91.3
52-Week Range ($) 0.1 - 1.24
Shares Outstanding (Mil) 38.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Agentix Corp Filings

Document Form Filing Date
No Filing Data

Agentix Corp Analysis

Share your research

Headlines

See More
No news.